Navigation Links
HeartWare International Announces Intention To Delist From Australian Securities Exchange (ASX)
Date:6/12/2013

FRAMINGHAM, Mass. and SYDNEY, June 12, 2013 /PRNewswire/ -- HeartWare International, Inc. (NASDAQ: HTWR - ASX:HIN), today announced that it has requested and received approval from ASX Limited for its removal from the official list of ASX.  Trading in HeartWare's CHESS Depositary Interests (CDIs) will be suspended on ASX at the close of market on September 10, 2013.

HeartWare's shares of common stock are currently listed for trading on the NASDAQ Global Select Market (NASDAQ) under the symbol HTWR and HeartWare's CDIs are traded on the ASX under the code HIN.  One share of HeartWare common stock is equivalent to 35 CDIs.

ASX has advised that in accordance with the Company's request, it will remove the Company from the official list of ASX with effect from the close of trading on September 17, 2013 subject to HeartWare providing a voluntary sale facility through which holders of CDIs may sell their shares of common stock on NASDAQ (as described below) and notifying CDI holders of the availability of the sale facility.  HeartWare's common stock will continue to be listed on NASDAQ.

Background on decision to delist

HeartWare Limited was admitted to the official list of ASX in 2005 and was replaced as the ASX listed entity by HeartWare following its redomiciliation in the United States in 2008.  Since HeartWare's listing on NASDAQ in 2009, there has been a substantial shift in the trading volume of its securities from ASX to NASDAQ, which has culminated in more than 99% of the total trading volume of HeartWare's securities occurring on NASDAQ and less than 1% of its trading volume occurring on ASX since January 1, 2013.  In addition, CDIs now only represent approximately 5% of HeartWare's issued and outstanding capital with the vast majority of its ca
'/>"/>

SOURCE HeartWare International, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. HeartWare Stock Trading Halted Today; FDA Advisory Committee to Review HeartWare® Ventricular Assist System as a Bridge to Heart Transplantation
2. Heartware Schedules First Quarter Conference Call And Webcast
3. HeartWare Presentation at the Bank of America Merrill Lynch 2012 Health Care Conference to be Webcast
4. HeartWare Completes Enrollment In 450-Patient Pivotal Destination Therapy Clinical Trial
5. HeartWare International Receives CE Mark Addendum, Expanding Label to Include All Patients at Risk of Death From Refractory, End-Stage Heart Failure
6. HeartWare Names Peter F. McAree Chief Financial Officer
7. HeartWare Schedules Second Quarter Conference Call And Webcast
8. HeartWare Completes Acquisition Of World Heart Corporation
9. HeartWare Reports Second Quarter 2012 Results
10. HeartWare Presentation at the 2012 Wedbush PacGrow Lifesciences Management Access Conference to be Webcast
11. HeartWare Presentation At The Canaccord Genuity 32nd Annual Growth Conference To Be Webcast
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/26/2014)... , Nov. 26, 2014  Aethlon Medical, Inc. ... definitive agreement to raise approximately $3.3 million at a ... made by one institutional healthcare focused investor. Each unit consists ... a common share purchase warrant. Each whole warrant entitles ... price of $0.30 for a period of five years ...
(Date:11/26/2014)... , Nov. 26, 2014  Cohen, Placitella ... behalf of investors who purchased Nymox Pharmaceutical Corporation ... during the period from January 31, 2011 through ... whether Nymox and certain of its officers and ... in violation of Sections 10(b) and 20(a) of ...
(Date:11/26/2014)... , Nov. 26, 2014 Lexicon ... announced the completion of previously announced concurrent financing ... After fees and estimated offering expenses, Lexicon anticipates ... transactions.  The transactions consisted of: , ... stock, pursuant to a registration statement that has ...
Breaking Medicine Technology:Aethlon Medical Announces $3.3 Million Equity Investment 2Aethlon Medical Announces $3.3 Million Equity Investment 3Cohen, Placitella & Roth, PC Investigating Nymox Pharmaceutical Corporation for Failing to Disclose Material Information 2Cohen, Placitella & Roth, PC Investigating Nymox Pharmaceutical Corporation for Failing to Disclose Material Information 3Lexicon Announces Completion Of $280 Million In Financing Transactions 2Lexicon Announces Completion Of $280 Million In Financing Transactions 3
(Date:11/27/2014)... Rosa, California (PRWEB) November 27, 2014 ... Bringing You An Up-Close Look At This Year’s Entries ... Of An All-Inclusive Stay For Two At Their Resort, ... High Times events or L.A.-based Hempcon, The Emerald Cup ... definitive county fair draws much of California’s original cannabis ...
(Date:11/27/2014)... In addition to a new dessert recipe ... this holiday season and become educated about the warning ... over the holidays may raise questions about the physical ... in cognitive ability can occur with age, serious memory ... the difference between normal aging and more serious problems ...
(Date:11/26/2014)... (PRWEB) November 26, 2014 Dr. Parsa ... themselves this holiday season! With Parsa Mohebi Hair Restoration’s ... off of their next FUE procedure, making it that ... FUE—which stands for “Follicular Unit Extraction”—is an advanced variety ... traditional “strip” Follicular Unit Transplantation (FUT). FUE, unlike FUT, ...
(Date:11/26/2014)... 27, 2014 Boxing Day is traditionally ... would receive gifts, known as a "Christmas box", from ... , With the coming of Boxing Day, some people ... smart before every business opportunity, and it has recently ... a site-wide promotion for its global customers. Then people ...
(Date:11/26/2014)... Dallas, Texas (PRWEB) November 26, 2014 ... surgeon and Distinguished Teaching Professor in the ... Center, recently discussed facial fat compartments, fat grafting, ... Surgery, The Meeting," an annual conference held by ... importance and intricacies of this underlying facial structure ...
Breaking Medicine News(10 mins):Health News:The Emerald Cup 2014 Competition Partners | CannCast – Bringing You An Up-Close Look At This Year’s Entries and SKUNK Magazine Proudly Sponsoring This Year's Grand Prize 2Health News:The Emerald Cup 2014 Competition Partners | CannCast – Bringing You An Up-Close Look At This Year’s Entries and SKUNK Magazine Proudly Sponsoring This Year's Grand Prize 3Health News:The Emerald Cup 2014 Competition Partners | CannCast – Bringing You An Up-Close Look At This Year’s Entries and SKUNK Magazine Proudly Sponsoring This Year's Grand Prize 4Health News:Alzheimer's Association Shares Tips to Navigate the Holiday Season 2Health News:Alzheimer's Association Shares Tips to Navigate the Holiday Season 3Health News:Alzheimer's Association Shares Tips to Navigate the Holiday Season 4Health News:Alzheimer's Association Shares Tips to Navigate the Holiday Season 5Health News:FUE Special at Parsa Mohebi Hair Restoration This Holiday Season 2Health News:Tbdress.com: Best Boxing Day Sales For Ladies Worldwide 2Health News:Dr. Rod J. Rohrich Discusses Facelifts at ASPS Annual Assembly 2Health News:Dr. Rod J. Rohrich Discusses Facelifts at ASPS Annual Assembly 3
... new UC Davis study shows how the brain reconfigures its ... knowledge of situations. "In order to behave efficiently, you ... but relevance is determined by your current situation," said Joy ... for Mind and Brain. For example, a flashing road ...
... Brain cancer cells are particularly resistant to chemotherapy toxins ... cells quickly pump them back outside. In fact, brain ... themselves. This means that when hit with chemotherapy, healthy cells ... brain, killing healthy cells is bad. Researchers at the ...
... , WEDNESDAY, Jan. 11 (HealthDay News) -- There ... herbal medicines to relieve the symptoms of osteoarthritis, according ... a painful condition that involves damage to cartilage and ... fingers, knees and hips. It differs from rheumatoid arthritis, ...
... at the California Institute of Technology (Caltech) has devised ... they have come up with should enable chemists to ... compounds called nitrogen-containing heterocycles, thus opening up new avenues ... ranging from chemotherapeutic compounds to bioactive plant materials such ...
... Reporter , WEDNESDAY, Jan. 11 (HealthDay News) -- Many ... are having an irregular heartbeat known as atrial fibrillation, ... a new study finds. Of 2,580 study participants ... atrial fibrillation, more than one-third experienced pacemaker-documented episodes that ...
... Health Sciences Center faculty and students made an economic ... regions of Kentucky served by UofL Area Health Education ... services valued at $5,606,599 while their students spent a ... the four regions. These regions encompass 56 counties that ...
Cached Medicine News:Health News:Selectively stopping glutathione sensitizes brain tumors to chemotherapy 2Health News:Herbal Medicines for Arthritis Not Backed by Evidence 2Health News:Herbal Medicines for Arthritis Not Backed by Evidence 3Health News:Caltech chemists devise chemical reaction that holds promise for new drug development 2Health News:Caltech chemists devise chemical reaction that holds promise for new drug development 3Health News:Even When Silent, Irregular Heartbeat Linked to Stroke Risk 2Health News:UofL centers have economic impact in excess of $5.7 million 2Health News:UofL centers have economic impact in excess of $5.7 million 3
The pouch is designed to protect the Digitrapper. The pouch strap can be worn on a belt loop or carried in a shoulder strap or backpack configuration....
... catheters are designed using established technology ... following benefits:, ,Working with pH ... where the multi-use catheter is used ... contact to the skin.,NOTE: ,Medtronic pH ...
...
... Designed to accommodate a variety of applications ... the AMAX DestinyPlus is suitable for any ... environment. With a mixed-mode throughput exceeding 95 ... perform a full range of chromogenics, the ...
Medicine Products: